Last reviewed · How we verify
Pneumococcal disease
Approved treatments
- Hospital-Based Vaccination Pathway · Pfizer
Pipeline
- 20-valent Pneumococcal Conjugate Vaccine · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pneumococcal disease patent landscape — cliff calendar, originator estates, attackable patents
- Pneumococcal disease treatment landscape brief
- Pneumococcal disease treatment updates RSS
Frequently asked questions about Pneumococcal disease
What drugs treat Pneumococcal disease?
Tracked treatments include Hospital-Based Vaccination Pathway.
What is the treatment for Pneumococcal disease?
Standard treatment for Pneumococcal disease includes Hospital-Based Vaccination Pathway. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Pneumococcal disease?
1 pipeline drugs tracked. Top candidates: 20-valent Pneumococcal Conjugate Vaccine.
Related
- Treatment landscape: Pneumococcal disease patent cliff · Pneumococcal disease CI report
- Treatment: Hospital-Based Vaccination Pathway · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing